Our PhD student Callum Flanagan presented his poster ‘Does cellular plasticity drive invasion in mesothelioma?’ at the first West Coast Cancer Meeting—a fantastic chance for local researchers to connect and share ideas!”

#NCARDresearch #mesothelioma #asbestosawareness

Turning loss into leadership: Corrine Naisbitt’s advocacy after mesothelioma – NCARD

This #NationalAsbestosAwarenessWeek & #NationalFamilyCaregiverMonth, meet NCARD Consumer Advisory Panel member, Corrine Naisbitt, who turned grief into advocacy after losing her husband Richard to mesothelioma.
ncard.org.au/turning-loss...
#Asbestosawareness #NCARDresearch

Prof Anna Nowak elected as iMig President – NCARD Professor Anna Nowak has been elected as President of the International Mesothelioma Interest Group (iMig) by her peers.

Congratulations to Prof Anna Nowak on her confirmation as President of iMig! Former NCARD Director (2018-22), now UWA DVC Research, Anna's leadership strengthens Australia's voice in global #mesothelioma research.

See you in Perth for #iMig2027! 🎉

ncard.org.au/prof-anna-no...

#NCARDresearch

Full house Monday night for NCARD's YURLU | COUNTRY screening at Windsor Cinema

Powerful Q&A with Prof Gary Lee, Dr Melvin Chin, Coreen Parker, Johnnell Parker & filmmaker Yaara Bou Melhem.

Thank you to all who joined us to #WalkWithBanjima
#NCARDresearch

ESMO® 2025 Highlights: Presenter Vignette - Anna Nowak - OncologyEducation Primary results of DREAM3R: DuRvalumab (MEDI4736) with chEmotherapy as first line treAtment in advanced pleural Mesothelioma – A phase 3 Randomised trial

Professor Anna Nowak presented DREAM3R trial results at ESMO Congress 2025 in Berlin - investigating durvalumab + chemo for advanced pleural #mesothelioma. A major step forward in Phase III research.

Watch highlights →
www.oncologyeducation.com/videos/esmo-...

#ESMO2025 #NCARDresearch

💜💛 Team NCARD/IRH at Relay For Life West Coast 💜💛

Last weekend we stood together with everyone who has heard "you have #cancer" - and showed our appreciation for the support our researchers receive from the Cancer Council.

#RelayForLife2025 #ncardresearch

2025 NCARD Annual Scientific Meeting – NCARD

Innovation meets collaboration at our 2025 ASM! 💙

From personalised imaging to mRNA vaccines, researchers & Consumer Advisory Panel members explored how science is improving outcomes for those affected by asbestos-related diseases.

ncard.org.au/2025-ncard-a...
#NCARDResearch #NCARDASM

Our 2025 ASM brought together ~40 researchers, students & Consumer Advisory Panel members on 18 Sept at
@perkinsinstitute.bsky.social ! 🔬

From imaging to immunotherapy - advancing care for those affected by asbestos-related diseases.
#NCARDResearch #NCARDASM

Welcoming Dr Onkar Nath to NCARD – NCARD

🧬 Welcome to the team, Dr Onkar Nath! Our new Research Associate brings 10+ years of #genomics & #bioinformatics expertise to help unlock how asbestos exposure causes disease. Excited to see the insights he'll bring to #NCARDresearch!
#mesothelioma
ncard.org.au/welcoming-dr...

Annual Report 2024 – NCARD

The 2024 NCARD Annual Report is now available. Read about our research progress and achievements in asbestos-related disease research: ncard.org.au/annual-repor...
Thanks to our researchers, clinicians, and supporters who make this vital work possible.
#mesothelioma #NCARDresearch

Your Gift, Their Hope: NCARD Biobank Donors Drive Lifesaving Discoveries – NCARD

It's #MesotheliomaAwarenessMonth - a time to honour those affected and celebrate the research that brings hope.
3,000+ donors. 50+ research projects.
Every biobank donation is a gift of hope. 💙
🔗 ncard.org.au/your-gift-th...
#NCARDresearch #Mesothelioma #MesotheliomaAwareness

New discovery could boost immunotherapy for mesothelioma patients - Cancer Council WA We hope that through this research, these drugs could be easily repurposed into the cancer clinic to help patients in the not-too-distant future.

🧬 Proud of our researcher Dr Nicola Principe, featured by Cancer Council WA for her innovative work using cholesterol-lowering drugs to boost immunotherapy for mesothelioma patients.
#ncardresearch #mesothelioma #immunotherapy

We recently welcomed @katechaneymp.bsky.social to NCARD for discussions on WA's #asbestos legacy and our #mesothelioma research.

Ms Chaney toured our labs and heard about our copper therapies, mRNA vaccines & Asbestos Review Program.

Thank you for your support!
#WAHealth #NCARDresearch

🔬 Our researchers use XRAD SmART platform for precision radio-immunotherapy research.

We're uncovering how radiotherapy reshapes tumour microenvironment to develop better personalised treatments for mesothelioma 🎯💪
#NCARDresearch #MesotheliomaResearch #precisionmedicine

Dr Kirsten Bennett awarded scholarship for safer dust disease screening research – NCARD The National Centre for Asbestos Related Diseases (NCARD) is pleased to share that Dr Kirsten Bennett has received a $100,000 PhD scholarship from the Dust Diseases Board to advance research into…

🎉Dr Kirsten Bennett awarded $100K PhD scholarship for innovative lung health monitoring research!
🔬Collaboration between Curtin Uni, the Institute for Respiratory Health & UWA
📍 Supervised by NCARD's Prof Fraser Brims
#DustDiseaseResearch #NCARDresearch

On #DaffodilDay 🌼, we recognise all those affected by cancer.
At NCARD, our research continues to advance understanding of mesothelioma and asbestos-related diseases, working toward better outcomes for patients and families. 🔬💛
#NCARDresearch #SupportCancerPatients #cancerresearch

Today is the first #MHFADay! 🧠💙
We recognise mental health challenges in academia. Proud our Kindness in Science team led our mental health strategy with full leadership support - including wellness reviews & MHFA training for supervisors.
#MakeEveryConversationMatter #NCARDresearch

Neoantigen load as a predictor of relapse in early-stage NSCLC: features that agonise and antagonise prognosis - Cancer Immunology, Immunotherapy Background Neoantigen-specific immune responses may help prevent cancer recurrence. We evaluated whether neoantigen load and/or properties could predict survival in early-stage non-small cell lung can...

🎉Congrats Dr Linda Ye & NCARD team on new publication!
Their findings suggest that certain characteristics of neoantigens could help identify which patients are at higher risk of recurrence.
link.springer.com/article/10.1...
#NCARDresearch #lungcancer #immunotherapy #immunology

🎉 NCARD students shine at 2025 WA ASMR meeting!

Huge congratulations to Honours student Mackenzie Lighton for winning the ASMR WA Travel Award & PhD student Faith Hartley for her excellent presentation 🧬👏

#NCARDresearch #ASMR

Our NCARD researchers presented at the
TSANZ WA Annual Scientific Meeting!

Dr Nicola Principe covered #mesothelioma chemo-immunotherapy & Kindness in Science while A/Prof Alec Redwood discussed personalised lung cancer vaccines.

#NCARDresearch

WeScience Podcast

🎙️ Our researcher, Dr François Rwandamuriye, features on WeScience Podcast Episode 3!

He shares his journey from Rwanda 🇷🇼 to Australia 🇦🇺, his work in tumour immunology & using mRNA technology for mesothelioma.
www.youtube.com/channel/UCxt...
#NCARDresearch #WeSciencePodcast

Ever wondered what happens after you donate a sample to research?

Our new patient info sheet explains how your contribution helps build a better future for people with asbestos-related diseases.

🔗 drive.google.com/file/d/10_tr...

#NCARDresearch #AsbestosRelatedDiseases #Biobank

Your Gift, Their Hope: NCARD Biobank Donors Drive Lifesaving Discoveries – NCARD More than 3,000 donors and their families have helped shape new tests, treatments and hope for the future.

30 years. 3,000+ donors. 50+ research projects. Countless lives impacted.

The NCARD Biobank transforms generous donations into real medical breakthroughs.

Every sample tells a story of hope. 💙

Learn more: ncard.org.au/your-gift-th...

#NCARDresearch #Biobank #MedicalResearch

Welcoming Dr Chloe Choi to NCARD – NCARD Dr Choi recently worked as a Technical Support Specialist at Abbott’s Diagnostic Division in Ireland. There, she focused on diagnostic assay development, data analysis, and laboratory troubleshooting – skills she brings to NCARD’s translational research efforts.

Welcome Dr Chloe Choi to #NCARD! 🎉

Dr Choi will help expand our ATTAC program into childhood cancers, exploring why #immunotherapy has been less effective in #paediatric patients.

ncard.org.au/welcoming-dr...

#CancerResearch #PaediatricCancer #WelcomeToTheTeam #NCARDresearch

Today is #WorldLungCancerDay. Asbestos exposure can cause #lungcancer - that's why the research our donors support matters so much.

3,000+ donors. 50+ research projects. Real breakthroughs in diagnosis and treatment.

Learn more: ncard.org.au/your-gift-th...
#NCARDresearch #CancerResearch

Thank you to Hon Dr Katrina Stratton MLC for visiting NCARD to hear about our work in #mesothelioma research, copper-targeting therapies and #mRNAvaccines.
#WAHealth #AsbestosAwareness #HealthPolicy #NCARDresearch

Mr Jonathan Huston MLA meets with NCARD researchers and staff during a roundtable discussion on asbestos-related disease research

Thank you to Mr Jonathan Huston MLA for visting NCARD to hear about our work in #mesothelioma research, #cancervaccines, clinical trials & equity-focused Aboriginal partnerships.
#WAHealth #AsbestosAwareness #HealthPolicy #NCARDresearch

Dr Alistair Cook sharing clinical trial insights with the community at the Asbestos Diseases Society of Australia this week! 🩺

From trial phases to current mesothelioma research - knowledge empowers patients & families. #NCARDresearch #ClinicalTrials #MesotheliomaResearch

Creating super cell power – NCARD

🧬 NCARD researchers are driving personalised mRNA cancer vaccine development at the Australian Centre for RNA Therapeutics.

Years of tumour research now powers cutting-edge RNA therapies! 🎯
ncard.org.au/creating-sup...
#CancerResearch #RNATherapeutics #NCARDresearch

Had an absolute blast at our X'mas in July event last week! ⛳🎄
SupaGolf + team lunch = perfect recipe for building those important workplace connections.
Nothing like a bit of friendly competition to bring the team😊
#NCARDresearch #TeamBuilding #ChristmasInJuly #WorkCulture